Nektar Therapeutics (NASDAQ:NKTR)

Monday’s trading has closed, but NKTR is being traded in the after-hours session. After-Hours quote »
10.56
Delayed Data
As of 4:00pm ET
 -0.21 / -1.95%
Today’s Change
10.32
Today|||52-Week Range
17.53
-31.87%
Year-to-Date

Today’s Trading

Previous close10.77
Today’s open10.85
Day’s range10.33 - 11.07
Volume1,520,408
Average volume (3 months)1,478,453
Market cap$1.4B
Dividend yield--
Data as of 4:00pm ET, 04/27/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)+8.27%
Earnings growth (next 5 years)-8.06%
Revenue growth (last year)+34.77%
P/E ratioNM
Price/Sales9.80
Price/Book38.90

Competitors

 Today’s
change
Today’s
% change
FGENFibroGen Inc-0.91-3.38%
NXTMNxStage Medical Inc-0.35-1.80%
KERXKeryx Biopharmaceuti...-0.39-3.42%
PRAHPRA Health Sciences ...-0.48-1.73%
Data as of 4:00pm ET, 04/27/2015

Financials

Next reporting dateMay 1, 2015
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers